![U8M U8M](https://data.pdbj.org/pdbjplus/data/cc/svg/U8M.svg) | U8M | Name: | 3-[(Z)-(2,3-difluorophenyl)diazenyl]pyridine-2,6-diamine | Formula: | C11 H9 F2 N5 | SMILES: | n1c(ccc(c1N)/N=Nc2cccc(F)c2F)N | InChi: | InChI=1S/C11H9F2N5/c12-6-2-1-3-7(10(6)13)17-18-8-4-5-9(14)16-11(8)15/h1-5H,(H4,14,15,16) | Definition date: | 2020-05-04 | Last modified: | 2020-12-18 | Release date: | 2020-12-23 | Identifier: | 3-[(Z)-(2,3-difluorophenyl)diazenyl]pyridine-2,6-diamine |
|
![UZD UZD](https://data.pdbj.org/pdbjplus/data/cc/svg/UZD.svg) | UZD | Name: | methyl 6-O-(heptylcarbamoyl)-beta-L-altropyranoside | Formula: | C15 H29 N O7 | SMILES: | O=C(OCC1OC(C(C(C1O)O)O)OC)NCCCCCCC | InChi: | InChI=1S/C15H29NO7/c1-3-4-5-6-7-8-16-15(20)22-9-10-11(17)12(18)13(19)14(21-2)23-10/h10-14,17-19H,3-9H2,1-2H3,(H,16,20)/t10-,11-,12-,13+,14-/m0/s1 | Definition date: | 2020-06-08 | Last modified: | 2020-12-18 | Release date: | 2020-12-23 | Identifier: | methyl 6-O-(heptylcarbamoyl)-beta-L-altropyranoside |
|
![V39 V39](https://data.pdbj.org/pdbjplus/data/cc/svg/V39.svg) | V39 | Name: | 3-{[6-(hydroxymethyl)pyridin-2-yl]methoxy}-2-methylphenol | Formula: | C14 H15 N O3 | SMILES: | Cc1c(cccc1O)OCc2cccc(n2)CO | InChi: | InChI=1S/C14H15NO3/c1-10-13(17)6-3-7-14(10)18-9-12-5-2-4-11(8-16)15-12/h2-7,16-17H,8-9H2,1H3 | Definition date: | 2020-06-11 | Last modified: | 2020-12-18 | Release date: | 2020-12-23 | Identifier: | 3-{[6-(hydroxymethyl)pyridin-2-yl]methoxy}-2-methylphenol |
|
![VC7 VC7](https://data.pdbj.org/pdbjplus/data/cc/svg/VC7.svg) | VC7 | Name: | 5'-O-[(R)-hydroxy(methyl)phosphoryl]guanosine | Formula: | C11 H16 N5 O7 P | SMILES: | C1(C(C(O)C(COP(C)(=O)O)O1)O)n3c2N=C(N)NC(c2nc3)=O | InChi: | InChI=1S/C11H16N5O7P/c1-24(20,21)22-2-4-6(17)7(18)10(23-4)16-3-13-5-8(16)14-11(12)15-9(5)19/h3-4,6-7,10,17-18H,2H2,1H3,(H,20,21)(H3,12,14,15,19)/t4-,6-,7-,10-/m1/s1 | Definition date: | 2020-07-27 | Last modified: | 2020-12-18 | Release date: | 2020-12-23 | Identifier: | 5'-O-[(R)-hydroxy(methyl)phosphoryl]guanosine |
|
![VHJ VHJ](https://data.pdbj.org/pdbjplus/data/cc/svg/VHJ.svg) | VHJ | Name: | N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3R)-2-oxo-3,4-dihydro-2H-pyrrol-3-yl]propan-2-yl}-L-phenylalaninamide | Formula: | C29 H38 N4 O6 | SMILES: | c1ccc(cc1)COC(NC(C(=O)NC(C(NC(CC2C(NCC2)=O)CO)=O)Cc3ccccc3)C(C)C)=O | InChi: | InChI=1S/C29H38N4O6/c1-19(2)25(33-29(38)39-18-21-11-7-4-8-12-21)28(37)32-24(15-20-9-5-3-6-10-20)27(36)31-23(17-34)16-22-13-14-30-26(22)35/h3-12,19,22-25,34H,13-18H2,1-2H3,(H,30,35)(H,31,36)(H,32,37)(H,33,38)/t22-,23-,24-,25-/m0/s1 | Definition date: | 2020-08-12 | Last modified: | 2020-12-18 | Release date: | 2020-12-23 | Identifier: | N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-phenylalaninamide |
|
![VHM VHM](https://data.pdbj.org/pdbjplus/data/cc/svg/VHM.svg) | VHM | Name: | N-[(benzyloxy)carbonyl]-L-valyl-3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide | Formula: | C29 H44 N4 O6 | SMILES: | c1ccc(cc1)COC(NC(C(C)C)C(=O)NC(C(NC(CC2C(NCC2)=O)CO)=O)CC3CCCCC3)=O | InChi: | InChI=1S/C29H44N4O6/c1-19(2)25(33-29(38)39-18-21-11-7-4-8-12-21)28(37)32-24(15-20-9-5-3-6-10-20)27(36)31-23(17-34)16-22-13-14-30-26(22)35/h4,7-8,11-12,19-20,22-25,34H,3,5-6,9-10,13-18H2,1-2H3,(H,30,35)(H,31,36)(H,32,37)(H,33,38)/t22-,23-,24-,25-/m0/s1 | Definition date: | 2020-08-12 | Last modified: | 2020-12-18 | Release date: | 2020-12-23 | Identifier: | N-[(benzyloxy)carbonyl]-L-valyl-3-cyclohexyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-alaninamide |
|
![VHP VHP](https://data.pdbj.org/pdbjplus/data/cc/svg/VHP.svg) | VHP | Name: | N-[(benzyloxy)carbonyl]-O-tert-butyl-L-threonyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | Formula: | C29 H46 N4 O7 | SMILES: | c1ccc(cc1)COC(NC(C(=O)NC(C(=O)NC(CC2C(NCC2)=O)CO)CC(C)C)C(C)OC(C)(C)C)=O | InChi: | InChI=1S/C29H46N4O7/c1-18(2)14-23(26(36)31-22(16-34)15-21-12-13-30-25(21)35)32-27(37)24(19(3)40-29(4,5)6)33-28(38)39-17-20-10-8-7-9-11-20/h7-11,18-19,21-24,34H,12-17H2,1-6H3,(H,30,35)(H,31,36)(H,32,37)(H,33,38)/t19-,21+,22+,23+,24+/m1/s1 | Definition date: | 2020-08-13 | Last modified: | 2020-12-18 | Release date: | 2020-12-23 | Identifier: | N-[(benzyloxy)carbonyl]-O-tert-butyl-L-threonyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide |
|
![VHV VHV](https://data.pdbj.org/pdbjplus/data/cc/svg/VHV.svg) | VHV | Name: | N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | Formula: | C26 H40 N4 O6 | SMILES: | c1ccc(cc1)COC(NC(C(C)C)C(=O)NC(C(NC(CO)CC2C(=O)NCC2)=O)CC(C)C)=O | InChi: | InChI=1S/C26H40N4O6/c1-16(2)12-21(24(33)28-20(14-31)13-19-10-11-27-23(19)32)29-25(34)22(17(3)4)30-26(35)36-15-18-8-6-5-7-9-18/h5-9,16-17,19-22,31H,10-15H2,1-4H3,(H,27,32)(H,28,33)(H,29,34)(H,30,35)/t19-,20-,21-,22-/m0/s1 | Definition date: | 2020-08-13 | Last modified: | 2020-12-18 | Release date: | 2020-12-23 | Identifier: | N-[(benzyloxy)carbonyl]-L-valyl-N-{(2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide |
|
![4DG 4DG](https://data.pdbj.org/pdbjplus/data/cc/svg/4DG.svg) | 4DG | Name: | 2-[(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl dihydrogen phosphate | Formula: | C8 H12 N5 O6 P | SMILES: | NC1=Nc2n(COCCO[P](O)(O)=O)cnc2C(=O)N1 | InChi: | InChI=1S/C8H12N5O6P/c9-8-11-6-5(7(14)12-8)10-3-13(6)4-18-1-2-19-20(15,16)17/h3H,1-2,4H2,(H2,15,16,17)(H3,9,11,12,14) | Synonyms: | acyclic guanosine monophosphate | Definition date: | 2009-11-09 | Last modified: | 2020-12-12 | Identifier: | 2-[(2-azanyl-6-oxo-1H-purin-9-yl)methoxy]ethyl dihydrogen phosphate |
|
![VXM VXM](https://data.pdbj.org/pdbjplus/data/cc/svg/VXM.svg) | VXM | Name: | 4-{[(5-fluoro-2-hydroxyphenyl)methyl]amino}-1H-isoindole-1,3(2H)-dione | Formula: | C15 H11 F N2 O3 | SMILES: | C1(NC(c2c1cccc2NCc3cc(F)ccc3O)=O)=O | InChi: | InChI=1S/C15H11FN2O3/c16-9-4-5-12(19)8(6-9)7-17-11-3-1-2-10-13(11)15(21)18-14(10)20/h1-6,17,19H,7H2,(H,18,20,21) | Definition date: | 2020-09-20 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 4-{[(5-fluoro-2-hydroxyphenyl)methyl]amino}-1H-isoindole-1,3(2H)-dione |
|
![VXP VXP](https://data.pdbj.org/pdbjplus/data/cc/svg/VXP.svg) | VXP | Name: | 4-{[(3-chloro-5-hydroxyphenyl)methyl]amino}-1H-isoindole-1,3(2H)-dione | Formula: | C15 H11 Cl N2 O3 | SMILES: | c1c(cc(O)cc1CNc3cccc2C(NC(=O)c23)=O)Cl | InChi: | InChI=1S/C15H11ClN2O3/c16-9-4-8(5-10(19)6-9)7-17-12-3-1-2-11-13(12)15(21)18-14(11)20/h1-6,17,19H,7H2,(H,18,20,21) | Definition date: | 2020-09-20 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 4-{[(3-chloro-5-hydroxyphenyl)methyl]amino}-1H-isoindole-1,3(2H)-dione |
|
![VXS VXS](https://data.pdbj.org/pdbjplus/data/cc/svg/VXS.svg) | VXS | Name: | 4-{[3-(2-hydroxyphenyl)propyl]amino}-1H-isoindole-1,3(2H)-dione | Formula: | C17 H16 N2 O3 | SMILES: | C(c1c(cccc1)O)CCNc3cccc2C(=O)NC(c23)=O | InChi: | InChI=1S/C17H16N2O3/c20-14-9-2-1-5-11(14)6-4-10-18-13-8-3-7-12-15(13)17(22)19-16(12)21/h1-3,5,7-9,18,20H,4,6,10H2,(H,19,21,22) | Definition date: | 2020-09-20 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 4-{[3-(2-hydroxyphenyl)propyl]amino}-1H-isoindole-1,3(2H)-dione |
|
![VXV VXV](https://data.pdbj.org/pdbjplus/data/cc/svg/VXV.svg) | VXV | Name: | 4-{[3-(3-chloro-5-hydroxyphenyl)propyl]amino}-1H-isoindole-1,3(2H)-dione | Formula: | C17 H15 Cl N2 O3 | SMILES: | C1(=O)c2c(C(N1)=O)c(ccc2)NCCCc3cc(cc(c3)O)Cl | InChi: | InChI=1S/C17H15ClN2O3/c18-11-7-10(8-12(21)9-11)3-2-6-19-14-5-1-4-13-15(14)17(23)20-16(13)22/h1,4-5,7-9,19,21H,2-3,6H2,(H,20,22,23) | Definition date: | 2020-09-20 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 4-{[3-(3-chloro-5-hydroxyphenyl)propyl]amino}-1H-isoindole-1,3(2H)-dione |
|
![W4Y W4Y](https://data.pdbj.org/pdbjplus/data/cc/svg/W4Y.svg) | W4Y | Name: | 1-{2-[(propan-2-yl)oxy]ethyl}-2-sulfanylidene-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-one | Formula: | C11 H15 N3 O2 S | SMILES: | C1(=O)NC(N(CCOC(C)C)c2ccnc12)=S | InChi: | InChI=1S/C11H15N3O2S/c1-7(2)16-6-5-14-8-3-4-12-9(8)10(15)13-11(14)17/h3-4,7,12H,5-6H2,1-2H3,(H,13,15,17) | Definition date: | 2020-09-29 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 1-{2-[(propan-2-yl)oxy]ethyl}-2-sulfanylidene-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-one |
|
![W51 W51](https://data.pdbj.org/pdbjplus/data/cc/svg/W51.svg) | W51 | Name: | 6-[(1s,4s)-2-azabicyclo[2.2.2]octan-2-yl]-5-chloropyrimidin-4-amine | Formula: | C11 H15 Cl N4 | SMILES: | C3C2CN(c1c(c(N)ncn1)Cl)C(CC2)C3 | InChi: | InChI=1S/C11H15ClN4/c12-9-10(13)14-6-15-11(9)16-5-7-1-3-8(16)4-2-7/h6-8H,1-5H2,(H2,13,14,15)/t7-,8+ | Definition date: | 2020-09-29 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 6-[(1s,4s)-2-azabicyclo[2.2.2]octan-2-yl]-5-chloropyrimidin-4-amine |
|
![W57 W57](https://data.pdbj.org/pdbjplus/data/cc/svg/W57.svg) | W57 | Name: | 3-[(3-methoxy-1,2-oxazol-5-yl)methyl]-3H-purin-6-amine | Formula: | C10 H10 N6 O2 | SMILES: | c3(CN2C=NC(=C1N=CN=C12)N)onc(c3)OC | InChi: | InChI=1S/C10H10N6O2/c1-17-7-2-6(18-15-7)3-16-5-14-9(11)8-10(16)13-4-12-8/h2,4-5H,3,11H2,1H3 | Definition date: | 2020-09-29 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 3-[(3-methoxy-1,2-oxazol-5-yl)methyl]-3H-purin-6-amine |
|
![W5A W5A](https://data.pdbj.org/pdbjplus/data/cc/svg/W5A.svg) | W5A | Name: | 3-[(2-methyl-1,3-thiazol-4-yl)methyl]-3H-purin-6-amine | Formula: | C10 H10 N6 S | SMILES: | c1(csc(n1)C)CN2C=3C(=C(N)N=C2)N=CN=3 | InChi: | InChI=1S/C10H10N6S/c1-6-15-7(3-17-6)2-16-5-14-9(11)8-10(16)13-4-12-8/h3-5H,2,11H2,1H3 | Definition date: | 2020-09-29 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 3-[(2-methyl-1,3-thiazol-4-yl)methyl]-3H-purin-6-amine |
|
![W5D W5D](https://data.pdbj.org/pdbjplus/data/cc/svg/W5D.svg) | W5D | Name: | 4-(1,4-oxazonan-4-yl)-7H-pyrrolo[2,3-d]pyrimidine | Formula: | C13 H18 N4 O | SMILES: | c2(c1ccnc1ncn2)N3CCOCCCCC3 | InChi: | InChI=1S/C13H18N4O/c1-2-6-17(7-9-18-8-3-1)13-11-4-5-14-12(11)15-10-16-13/h4-5,10H,1-3,6-9H2,(H,14,15,16) | Definition date: | 2020-09-29 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 4-(1,4-oxazonan-4-yl)-7H-pyrrolo[2,3-d]pyrimidine |
|
![W5G W5G](https://data.pdbj.org/pdbjplus/data/cc/svg/W5G.svg) | W5G | Name: | 4-(5-azaspiro[2.5]octan-5-yl)-7H-pyrrolo[2,3-d]pyrimidine | Formula: | C13 H16 N4 | SMILES: | n2c1nccc1c(nc2)N4CCCC3(CC3)C4 | InChi: | InChI=1S/C13H16N4/c1-3-13(4-5-13)8-17(7-1)12-10-2-6-14-11(10)15-9-16-12/h2,6,9H,1,3-5,7-8H2,(H,14,15,16) | Definition date: | 2020-09-29 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 4-(5-azaspiro[2.5]octan-5-yl)-7H-pyrrolo[2,3-d]pyrimidine |
|
![W5J W5J](https://data.pdbj.org/pdbjplus/data/cc/svg/W5J.svg) | W5J | Name: | N-methyl-N-7H-pyrrolo[2,3-d]pyrimidin-4-yl-beta-alanine | Formula: | C10 H12 N4 O2 | SMILES: | c1nc2nccc2c(n1)N(C)CCC(O)=O | InChi: | InChI=1S/C10H12N4O2/c1-14(5-3-8(15)16)10-7-2-4-11-9(7)12-6-13-10/h2,4,6H,3,5H2,1H3,(H,15,16)(H,11,12,13) | Definition date: | 2020-09-29 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | N-methyl-N-7H-pyrrolo[2,3-d]pyrimidin-4-yl-beta-alanine |
|
![W5P W5P](https://data.pdbj.org/pdbjplus/data/cc/svg/W5P.svg) | W5P | Name: | 4-[(3R)-3-fluoropiperidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine | Formula: | C11 H13 F N4 | SMILES: | c1nc3nccc3c(n1)N2CCCC(F)C2 | InChi: | InChI=1S/C11H13FN4/c12-8-2-1-5-16(6-8)11-9-3-4-13-10(9)14-7-15-11/h3-4,7-8H,1-2,5-6H2,(H,13,14,15)/t8-/m1/s1 | Definition date: | 2020-09-29 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 4-[(3R)-3-fluoropiperidin-1-yl]-7H-pyrrolo[2,3-d]pyrimidine |
|
![W5S W5S](https://data.pdbj.org/pdbjplus/data/cc/svg/W5S.svg) | W5S | Name: | 7-[(furan-2-yl)methyl]-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | Formula: | C13 H14 N4 O | SMILES: | n1(c2c(c(c1C)C)c(ncn2)N)Cc3ccco3 | InChi: | InChI=1S/C13H14N4O/c1-8-9(2)17(6-10-4-3-5-18-10)13-11(8)12(14)15-7-16-13/h3-5,7H,6H2,1-2H3,(H2,14,15,16) | Definition date: | 2020-09-29 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 7-[(furan-2-yl)methyl]-5,6-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
|
![W6G W6G](https://data.pdbj.org/pdbjplus/data/cc/svg/W6G.svg) | W6G | Name: | N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide | Formula: | C8 H7 N3 O2 S2 | SMILES: | c1(ccccc1)S(Nc2scnn2)(=O)=O | InChi: | InChI=1S/C8H7N3O2S2/c12-15(13,7-4-2-1-3-5-7)11-8-10-9-6-14-8/h1-6H,(H,10,11) | Definition date: | 2020-09-29 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide |
|
![W6M W6M](https://data.pdbj.org/pdbjplus/data/cc/svg/W6M.svg) | W6M | Name: | 3-{[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]carbamoyl}benzoic acid | Formula: | C12 H11 N3 O4 | SMILES: | c2(C(NCc1nc(C)no1)=O)cccc(C(O)=O)c2 | InChi: | InChI=1S/C12H11N3O4/c1-7-14-10(19-15-7)6-13-11(16)8-3-2-4-9(5-8)12(17)18/h2-5H,6H2,1H3,(H,13,16)(H,17,18) | Definition date: | 2020-09-29 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | 3-{[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]carbamoyl}benzoic acid |
|
![W6V W6V](https://data.pdbj.org/pdbjplus/data/cc/svg/W6V.svg) | W6V | Name: | N-(1,3-thiazol-2-yl)benzamide | Formula: | C10 H8 N2 O S | SMILES: | c2c(C(=O)Nc1nccs1)cccc2 | InChi: | InChI=1S/C10H8N2OS/c13-9(8-4-2-1-3-5-8)12-10-11-6-7-14-10/h1-7H,(H,11,12,13) | Definition date: | 2020-09-29 | Last modified: | 2020-12-11 | Release date: | 2020-12-16 | Identifier: | N-(1,3-thiazol-2-yl)benzamide |
|